← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL: NOT EVERY POPULATION IMPROVES. (2018/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Boceprevir-induced Herpes Zoster. (2018/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems. (2018/06/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of the extrahepatic manifestations of chronic hepatitis C infection. (2018/06/05) ♡
• Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India. (2018/06/01) ♡
• State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015. (2018/06/01) ♡
• Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. (2018/06/01) ♡
• Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease. (2018/06/01) ♡
• Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up. (2018/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe hyponatremia after direct-acting antiviral treatment in a patient with virus C compensated liver cirrhosis and kidney transplant. (2018/06/01) ♡
• Th17 and IL-17 as Predictors of Hepatic Inflammation in Patients with Chronic Hepatitis C Virus Infection and Treated With Direct Antiviral Therapy. (2018/06/01) ♡
• Impact of weight reduction on selected immune system response among Hepatitis C virus Saudi patients. (2018/06/01) ♡
• Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. (2018/05/16) ♡
• Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. (2018/05/01) ♡
• Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment. (2018/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?". (2018/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. "Who killed JR": Chronic hepatitis C or alcohol use disorders? (2018/05/01) ♡
• Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV). (2018/05/01) ♡
• Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4. (2018/05/01) ♡
• Hepatitis C virus core protein induces hepatic steatosis via Sirt1-dependent pathway. (2018/05/01) ♡
• Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling. (2018/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: patient-reported outcomes in chronic HCV-a PROMISing approach to an ongoing problem. (2018/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. (2018/05/01) ♡
• Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents. (2018/05/01) ♡
• The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus. (2018/04/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV. (2018/04/15) ♡
• Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids. (2018/04/12) ♡
• Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection. (2018/04/04) ♡
• Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers. (2018/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain. (2018/04/01) ♡
• The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health Records. (2018/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. (2018/04/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials. (2018/04/01) ♡
• Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection. (2018/04/01) ♡
• Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C. (2018/04/01) ♡
• Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy. (2018/04/01) ♡
• Treatment of HCV in the Department of Corrections in the Era of Oral Medications. (2018/04/01) ♡
• Chapter 6.1. Pediatric Chronic Hepatitis B and C: 30 Years of ESPGHAN Clinical Research and Recommendations. (2018/04/01) ♡
• Bioelectrical Impedance Analysis-Derived Measurements in Chronic Hepatitis C: Clinical Relevance of Fat-Free Mass and Phase Angle Evaluation. (2018/04/01) ♡
• The Association Between Helicobacter Pylori Infection and Liver and Biliary Tract Disorders. (2018/04/01) ♡
• Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. (2018/03/21) ♡
• Joint modeling of multiple ordinal adherence outcomes via generalized estimating equations with flexible correlation structure. (2018/03/15) ♡
• Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian population. (2018/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. NS5B polymerase inhibitors in phase II clinical trials for HCV infection. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of Coinfections in Patients with Human Immunodeficiency Virus. (2018/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Genetic and clinical data predict onset of cryoglobulinemia in HCV patients and cryoglobulins clearance. (2018/03/01) ♡
• Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road? (2018/03/01) ♡
• Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir. (2018/03/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.